Virtual Event
- This event has passed.
Success Stories and Lessons Learned from Recent FDA Approvals
October 29, 2025 @ 10:00 am - 2:00 pm
Virtual Event
ATTRUBY (Acoramidis) from BridgeBio for the Treatment of Transthyretin Amyloidosis (ATTR-CM) (Co-organized with Stanford SPARK Platform)